The concept of personalized medicine is only 15 years old. But already, we can see how physicians and patients will draw upon a wealth of new genetic and biological data to make personalized therapy the norm. For healthcare businesses, that vision is preparing the way for a fundamentally new and game-changing value proposition. The greatest impact will probably be felt in the pharmaceutical industry. But the implications for patients, payors, hospitals, equipment manufacturers, and physicians are also enormous. What are these implications? Why are they emerging now? What will they mean for you as a patient, taxpayer, and investor? We’ll show you.
- Digitalization Drives Prosperity
- Driverless Cars: Coming to Your Street Sooner Than You Think